{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:06:42Z","timestamp":1779095202926,"version":"3.51.4"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Screening tests are crucial for detecting diseases at preclinical stages when timely intervention can prevent progression to more severe conditions. Advances in technology have facilitated developing screening tests based on novel markers, but evaluating their performance using biospecimens from large cohorts remains logistically complex and financially demanding. Two-phase designs offer a cost-effective solution by allowing inference when expensive marker measurements are collected on only a carefully selected subsample. While traditional two-phase designs have primarily targeted estimation of marker-outcome associations, they can effectively be extended to evaluate the clinical performance of a test, including estimation of positive predictive value (the risk in test positives) and complementary negative predictive value (the risk in test negatives). We propose a novel two-phase design for efficiently evaluating the risk-stratification utility of screening tests in distinguishing between high- and low-risk individuals for both current and future disease. Designed for use with biospecimens collected from screening studies, our methodology accommodates cohorts that include both pre-existing cases at an initial screening visit and new cases identified during follow-up. We demonstrate the efficiency gains of our proposed design compared to other subsampling schemes through simulation and illustrate its application in a motivating study evaluating the p16\/ki-67 dual-stain test for managing human papillomavirus-positive women in cervical cancer screening. Data and stored biospecimen samples from Kaiser Permanente Northern California are used in this analysis.<\/jats:p>","DOI":"10.1093\/biomtc\/ujag058","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T12:35:56Z","timestamp":1774096556000},"source":"Crossref","is-referenced-by-count":0,"title":["Two-phase designs for cost-effective evaluation of cancer screening tests"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1162-4348","authenticated-orcid":false,"given":"Fangya","family":"Mao","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH , Rockville, MD 20850 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1414-4908","authenticated-orcid":false,"given":"Richard J","family":"Cook","sequence":"additional","affiliation":[{"name":"University of Waterloo Department of Statistics and Actuarial Science, , Waterloo, ON N2L 3G1 ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9075-1515","authenticated-orcid":false,"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[{"name":"Regional Laboratory, Kaiser Permanente Northern California , Berkeley, CA 94710 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1251-0836","authenticated-orcid":false,"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH , Rockville, MD 20850 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-4331","authenticated-orcid":false,"given":"Li C","family":"Cheung","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH , Rockville, MD 20850 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"2026051804115727100_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-4818-1","volume-title":"Essential Statistical Inference: Theory and Methods","author":"Boos","year":"2013"},{"key":"2026051804115727100_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/biomet\/75.1.11","article-title":"Logistic regression for two-stage case-control data","volume":"75","author":"Breslow","year":"1988","journal-title":"Biometrika"},{"key":"2026051804115727100_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/biostatistics\/kxr021","article-title":"Evaluating prognostic accuracy of biomarkers in nested case\u2013control studies","volume":"13","author":"Cai","year":"2012","journal-title":"Biostatistics (Oxford, England)"},{"key":"2026051804115727100_bib4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/biostatistics\/kxab044","article-title":"Two-phase stratified sampling and analysis for predicting binary outcomes","volume":"24","author":"Cao","year":"2023","journal-title":"Biostatistics (Oxford, England)"},{"key":"2026051804115727100_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/biomet\/86.4.755","article-title":"Case-cohort and case-control analysis with Cox\u2019s model","volume":"86","author":"Chen","year":"1999","journal-title":"Biometrika"},{"key":"2026051804115727100_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/LGT.0000000000000528","article-title":"2019 ASCCP risk-based management consensus guidelines: methods for risk estimation, recommended management, and validation","volume":"24","author":"Cheung","year":"2020","journal-title":"Journal of Lower Genital Tract Disease"},{"key":"2026051804115727100_bib7","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1002\/sim.7380","article-title":"Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records","volume":"36","author":"Cheung","year":"2017","journal-title":"Statistics in Medicine"},{"key":"2026051804115727100_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/LGT.0000000000000802","article-title":"Recommendations for use of p16\/Ki67 dual stain for management of individuals testing positive for Human Papillomavirus","volume":"28","author":"Clarke","year":"2024","journal-title":"Journal of Lower Genital Tract Disease"},{"key":"2026051804115727100_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/LGT.0000000000000667","article-title":"Contribution of etiologic cofactors to CIN3+ risk Among women with human papillomavirus\u2013positive screening test results","volume":"26","author":"Demarco","year":"2022","journal-title":"Journal of Lower Genital Tract Disease"},{"key":"2026051804115727100_bib10","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2307\/2529885","article-title":"The use of mixture models for the analysis of survival data with long-term survivors","volume":"38","author":"Farewell","year":"1982","journal-title":"Biometrics"},{"key":"2026051804115727100_bib11","article-title":"premarket approval: cintec plus cytology","author":"FDA US Food and Drug Administration","year":"2020"},{"key":"2026051804115727100_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2307\/2530698","article-title":"A proportional hazards model for interval-censored failure time data","volume":"42","author":"Finkelstein","year":"1986","journal-title":"Biometrics"},{"key":"2026051804115727100_bib13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.0006-341X.1999.01193.x","article-title":"Design of validation studies for estimating the odds ratio of exposure\u2013disease relationships when exposure is misclassified","volume":"55","author":"Holcroft","year":"1999","journal-title":"Biometrics"},{"key":"2026051804115727100_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/biostatistics\/kxw003","article-title":"Evaluating and comparing biomarkers with respect to the area under the receiver operating characteristics curve in two-phase case\u2013control studies","volume":"17","author":"Huang","year":"2016","journal-title":"Biostatistics (Oxford, England)"},{"key":"2026051804115727100_bib15","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/sim.3876","article-title":"Assessing risk prediction models in case\u2013control studies using semiparametric and nonparametric methods","volume":"29","author":"Huang","year":"2010","journal-title":"Statistics in Medicine"},{"key":"2026051804115727100_bib16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1214\/17-AOAS1036","article-title":"Flexible risk prediction models for left or interval-censored data from electronic health records","volume":"11","author":"Hyun","year":"2017","journal-title":"The Annals of Applied Statistics"},{"key":"2026051804115727100_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10985-016-9386-8","article-title":"Two-phase outcome-dependent studies for failure times and testing for effects of expensive covariates","volume":"24","author":"Lawless","year":"2018","journal-title":"Lifetime Data Analysis"},{"key":"2026051804115727100_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/OLQ.0000000000001356","article-title":"Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States","volume":"48","author":"Lewis","year":"2021","journal-title":"Sexually Transmitted Diseases"},{"key":"2026051804115727100_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/9781119482260","volume-title":"Statistical Analysis With Missing Data, Third Edition","author":"Little","year":"2019"},{"key":"2026051804115727100_bib20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1541-0420.2012.01787.x","article-title":"Evaluating the predictive value of biomarkers with stratified case-cohort design","volume":"68","author":"Liu","year":"2012","journal-title":"Biometrics"},{"key":"2026051804115727100_bib21","doi-asserted-by":"crossref","first-page":"ujad038","DOI":"10.1093\/biomtc\/ujad038","article-title":"Two-phase designs with failure time processes subject to nonsusceptibility","volume":"80","author":"Mao","year":"2024","journal-title":"Biometrics"},{"key":"2026051804115727100_bib22","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/sim.9666","article-title":"Two-phase designs with current status data","volume":"42","author":"Mao","year":"2023","journal-title":"Statistics in Medicine"},{"key":"2026051804115727100_bib23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jrsssc\/qlae028","article-title":"Two-phase biomarker studies for disease progression with multiple registries","volume":"73","author":"Mao","year":"2024","journal-title":"Journal of the Royal Statistical Society Series C: Applied Statistics"},{"key":"2026051804115727100_bib24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cjs.11207","article-title":"Response-dependent two-phase sampling designs for biomarker studies","volume":"42","author":"McIsaac","year":"2014","journal-title":"Canadian Journal of Statistics"},{"key":"2026051804115727100_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"Journal of Lower Genital Tract Disease"},{"key":"2026051804115727100_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biomet\/73.1.1","article-title":"A case-cohort design for epidemiologic cohort studies and disease prevention trials","volume":"73","author":"Prentice","year":"1986","journal-title":"Biometrika"},{"key":"2026051804115727100_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/1467-9469.00177","article-title":"Consistency of the GMLE with mixed case interval-censored data","volume":"27","author":"Schick","year":"2000","journal-title":"Scandinavian Journal of Statistics"},{"key":"2026051804115727100_bib28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5858\/arpa.2012-0198-RA","article-title":"Understanding sources of bias in diagnostic accuracy studies","volume":"137","author":"Schmidt","year":"2013","journal-title":"Archives of pathology and laboratory medicine"},{"key":"2026051804115727100_bib29","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1080\/01621459.2019.1671200","article-title":"Optimal designs of two-phase studies","volume":"115","author":"Tao","year":"2020","journal-title":"Journal of the American Statistical Association"},{"key":"2026051804115727100_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/biom.13140","article-title":"Novel two-phase sampling designs for studying binary outcomes","volume":"76","author":"Wang","year":"2020","journal-title":"Biometrics."},{"key":"2026051804115727100_bib31","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamainternmed.2019.0306","article-title":"Clinical evaluation of human papillomavirus screening with p16\/Ki-67 dual stain triage in a large organized cervical cancer screening program","volume":"179","author":"Wentzensen","year":"2019","journal-title":"JAMA Internal Medicine"},{"key":"2026051804115727100_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/LGT.0000000000000804","article-title":"Enduring consensus guidelines for cervical cancer screening and management: Introduction to the scope and process","volume":"28","author":"Wentzensen","year":"2024","journal-title":"Journal of Lower Genital Tract Disease"},{"key":"2026051804115727100_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jnci\/djaa066","article-title":"Accuracy and efficiency of deep-learning\u2013based automation of dual stain cytology in cervical cancer screening","volume":"113","author":"Wentzensen","year":"2021","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"2026051804115727100_bib34","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"Journal of Clinical Virology"},{"key":"2026051804115727100_bib35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1214\/16-AOAS997","article-title":"Improving efficiency in biomarker incremental value evaluation under two-phase designs","volume":"11","author":"Zheng","year":"2017","journal-title":"The Annals of Applied Statistics"}],"container-title":["Biometrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biometrics\/article-pdf\/82\/2\/ujag058\/68165438\/ujag058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biometrics\/article-pdf\/82\/2\/ujag058\/68165438\/ujag058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:12:26Z","timestamp":1779091946000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biometrics\/article\/doi\/10.1093\/biomtc\/ujag058\/8663020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,9]]}},"URL":"https:\/\/doi.org\/10.1093\/biomtc\/ujag058","relation":{},"ISSN":["0006-341X","1541-0420"],"issn-type":[{"value":"0006-341X","type":"print"},{"value":"1541-0420","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,9]]},"article-number":"ujag058"}}